rs150016894
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_144991.3(TSPEAR):c.151G>A(p.Val51Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00167 in 1,593,350 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_144991.3 missense
Scores
Clinical Significance
Conservation
Publications
- ectodermal dysplasia 14, hair/tooth type with or without hypohidrosisInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive nonsyndromic hearing loss 98Inheritance: AR Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TSPEAR | ENST00000323084.9 | c.151G>A | p.Val51Ile | missense_variant | Exon 2 of 12 | 1 | NM_144991.3 | ENSP00000321987.4 | ||
| TSPEAR | ENST00000397916.1 | n.106G>A | non_coding_transcript_exon_variant | Exon 2 of 11 | 1 | |||||
| TSPEAR | ENST00000642437.1 | n.*96G>A | non_coding_transcript_exon_variant | Exon 3 of 13 | ENSP00000496535.1 | |||||
| TSPEAR | ENST00000642437.1 | n.*96G>A | 3_prime_UTR_variant | Exon 3 of 13 | ENSP00000496535.1 |
Frequencies
GnomAD3 genomes AF: 0.00129 AC: 196AN: 152154Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00105 AC: 255AN: 242878 AF XY: 0.00113 show subpopulations
GnomAD4 exome AF: 0.00171 AC: 2470AN: 1441078Hom.: 3 Cov.: 30 AF XY: 0.00170 AC XY: 1217AN XY: 714966 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00129 AC: 196AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.00113 AC XY: 84AN XY: 74468 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
- -
- -
- -
not specified Benign:1
p.Val51Ile in exon 2 of TSPEAR: This variant is not expected to have clinical si gnificance due to a lack of conservation across species, including mammals. Of n ote, 6 mammals have an isoleucine (Ile) at this position. In addition, computati onal prediction tools do not suggest a high likelihood of impact to the protein. Furthermore, this variant has been identified in 0.15% (97/65584) of European c hromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute .org; dbSNP rs150016894). -
TSPEAR-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at